Primary central nervous system lymphoma imaged with FDG-PET/CT

被引:0
|
作者
Marti Samper, Alejandro [1 ]
机构
[1] Inst Nacl Cancerol, Grp Med Nucl PET, Bogota, Colombia
来源
REVISTA COLOMBIANA DE CANCEROLOGIA | 2013年 / 17卷 / 03期
关键词
Positron emission tomography; Primary central nervous system lymphoma; Staging;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary central nervous system lymphoma (PCNSL) is now known as a form of non-Hodgkin extranodal high-grade B-cell, usually diffuse large B cell, originating in the brain, leptomeninges, spinal cord or eyes, and usually remains confined to the central nervous system (CNS). The main risk factor is immunodeficiency. It represents 4% of primary CNS tumors, with an incidence rate adjusted for age of 4/1,000,000/year. Positron emission tomography (PET) has shown to have an impact on staging impact patients with diffuse large B cell lymphoma, but there is limited experience in cases of primary CNS involvement. (C) 2013 Instituto Nacional de Cancerologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:126 / 129
页数:4
相关论文
共 50 条
  • [1] Utility of FDG-PET in initial assessment of primary central nervous system lymphoma
    Bertaux, M.
    Kas, A.
    Soussain, C.
    Veronique, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S313 - S313
  • [2] FDG-PET Is An Independent Predictor for Survival in Primary Central Nervous System Lymphoma
    Kasenda, Benjamin
    Haug, Vanessa
    Schorb, Elisabeth
    Fritsch, Kristina
    Weber, Wolfgang
    Finke, Jurgen
    Illerhaus, Gerald
    Meyer, Philipp T.
    BLOOD, 2011, 118 (21) : 1154 - 1155
  • [3] Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study
    Bertaux, Marc
    Houillier, Caroline
    Edeline, Veronique
    Habert, Marie-Odile
    Mokhtari, Karima
    Giron, Alain
    Bergeret, Sebastien
    Hoang-Xuan, Khe
    Cassoux, Nathalie
    Touitou, Valerie
    Choquet, Sylvain
    Soussain, Carole
    Kas, Aurelie
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (02) : 343 - 352
  • [4] Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study
    Marc Bertaux
    Caroline Houillier
    Véronique Edeline
    Marie-Odile Habert
    Karima Mokhtari
    Alain Giron
    Sébastien Bergeret
    Khe Hoang-Xuan
    Nathalie Cassoux
    Valérie Touitou
    Sylvain Choquet
    Carole Soussain
    Aurélie Kas
    Journal of Neuro-Oncology, 2020, 148 : 343 - 352
  • [5] Primary Pituitary Lymphoma Diagnosis by FDG-PET/CT
    Hayasaka, Kazumasa
    Koyama, Masamichi
    Yamashita, Takashi
    CLINICAL NUCLEAR MEDICINE, 2010, 35 (03) : 205 - 205
  • [6] CLINICAL UTILITY OF FDG-PET/CT FOR DIAGNOSIS AND STAGING IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: PROSPECTIVE SINGLE ARM STUDY
    Gupta, T.
    Gupta, M.
    Rangarajan, V.
    Purandare, N.
    Sastri, G.
    Menon, H.
    Moiyadi, A.
    Shetty, P.
    Epari, S.
    Jalali, R.
    NEURO-ONCOLOGY, 2017, 19 : 107 - 108
  • [7] FDG-PET in immunocompetent patients with primary central nervous system lymphoma: differentiation from GBM and correlation with DWI
    Zhou, Weiyan
    Wen, Jianbo
    Hua, Fengchun
    Guan, Yihui
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [8] The utility of body FDG PET in staging primary central nervous system lymphoma
    Mohile, Nimish A.
    DeAngelis, Lisa M.
    Abrey, Lauren E.
    NEURO-ONCOLOGY, 2008, 10 (02) : 223 - 228
  • [9] Primary central nervous system lymphoma: is whole-body CT and FDG PET/CT for initial imaging reasonable?
    Malikova, Hana
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2019, 9 (09) : 1615 - 1618
  • [10] Primary Central Nervous System Lymphoma and Meningioma in DOTATATE PET/CT
    Lapa, Constantin
    Loehr, Mario
    Bluemel, Christina
    Monoranu, Camelia Maria
    Herrmann, Ken
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (12) : 994 - 995